<SEC-DOCUMENT>0001628280-21-024264.txt : 20211201
<SEC-HEADER>0001628280-21-024264.hdr.sgml : 20211201
<ACCEPTANCE-DATETIME>20211130175259
ACCESSION NUMBER:		0001628280-21-024264
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20211130
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20211201
DATE AS OF CHANGE:		20211130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		211460631

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cpix-20211130.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:7410dd42-56a6-4617-b36d-8314ad02a0de,g:2b92fc42-55d8-4534-9ce1-84689eef7112,d:e4b0cbdd6d874801a10a304ed1b6c63e--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cpix-20211130</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xMC9mcmFnOjg0OTI5YzM0MTMyMzRkYmQ5ZWEyNzZhNTBjNDdhOWI4L3RhYmxlOjQ5OTE4Y2YxNWJhZjRjODdhNzY4MDI0OTM5NWNjYTRhL3RhYmxlcmFuZ2U6NDk5MThjZjE1YmFmNGM4N2E3NjgwMjQ5Mzk1Y2NhNGFfMi0xLTEtMS0xMjM3NQ_a9871e7e-ef46-47a8-8bc5-18b91291fac1">0001087294</ix:nonNumeric><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xMC9mcmFnOjg0OTI5YzM0MTMyMzRkYmQ5ZWEyNzZhNTBjNDdhOWI4L3RhYmxlOjQ5OTE4Y2YxNWJhZjRjODdhNzY4MDI0OTM5NWNjYTRhL3RhYmxlcmFuZ2U6NDk5MThjZjE1YmFmNGM4N2E3NjgwMjQ5Mzk1Y2NhNGFfMy0xLTEtMS0xMjM3NQ_eb811f46-5b60-452f-8826-bc3942b15761">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cpix-20211130.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-11-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie4b0cbdd6d874801a10a304ed1b6c63e_1"></div><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAw_b4e268d1-43cb-4ca4-b29c-85301825fb87">8-K</ix:nonNumeric> </span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzY_a8a1f2a3-fed2-4a3c-8f6a-e0bc3f33c812">November 30, 2021</ix:nonNumeric> (November 29, 2021)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAx_1f60eb61-433c-4af9-8364-c18cc44012bc">CUMBERLAND PHARMACEUTICALS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6Y2ZlYTRjN2I1OTNlNDliOThkZjU0MDVmNjE4MWQ2YjIvdGFibGVyYW5nZTpjZmVhNGM3YjU5M2U0OWI5OGRmNTQwNWY2MTgxZDZiMl8wLTAtMS0xLTEyMzc1_8a8aca24-6b25-45df-bd09-e1a263a0dbcc">Tennessee</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6Y2ZlYTRjN2I1OTNlNDliOThkZjU0MDVmNjE4MWQ2YjIvdGFibGVyYW5nZTpjZmVhNGM3YjU5M2U0OWI5OGRmNTQwNWY2MTgxZDZiMl8wLTEtMS0xLTEyMzc1_eb8a4631-acc5-481f-befb-02fdb0da5897">001-33637</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6Y2ZlYTRjN2I1OTNlNDliOThkZjU0MDVmNjE4MWQ2YjIvdGFibGVyYW5nZTpjZmVhNGM3YjU5M2U0OWI5OGRmNTQwNWY2MTgxZDZiMl8wLTMtMS0xLTEyMzc1_527d8ba5-1cb6-4093-b265-24a6388b880e">62-1765329</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAy_584cd7c8-d548-48bd-b96c-794c5407e3b2">2525 West End Avenue, Suite 950</ix:nonNumeric> <ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk2_152f9235-c113-42bf-9526-92c066be93db">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAz_5ecf761a-60d8-4122-afe1-28ac425da629">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA0_f7392f81-e683-4151-9b2f-4f8a49b4d37f">37203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(Address of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA1_558821c7-ba1a-4765-85d3-32941e88bd9d">615</ix:nonNumeric>) <ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk3_5b0e9a6f-52b8-415b-be52-f783fcc52c8a">255-0068</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Registrant's telephone number, including area code</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA2_15083984-2a50-43ac-a181-9a5706490f36">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA3_d5ee83f7-0b1e-4dee-8961-a18f2ee063ae">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk4_b9ea5fc2-30c4-463c-8959-26a59caf5e3e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk5_f94b1721-ff33-4692-9b79-11f417807c4b">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6OTU4ZjNmODA1NjM4NGI5YzhlYzM0NzdhMzdkODIzNjcvdGFibGVyYW5nZTo5NThmM2Y4MDU2Mzg0YjljOGVjMzQ3N2EzN2Q4MjM2N18xLTAtMS0xLTEyMzc1_4316548f-33b2-4f54-a370-2f3f2bc08a96">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6OTU4ZjNmODA1NjM4NGI5YzhlYzM0NzdhMzdkODIzNjcvdGFibGVyYW5nZTo5NThmM2Y4MDU2Mzg0YjljOGVjMzQ3N2EzN2Q4MjM2N18xLTEtMS0xLTEyMzc1_97d27146-f886-4212-8426-4c6488439ae7">CPIX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6OTU4ZjNmODA1NjM4NGI5YzhlYzM0NzdhMzdkODIzNjcvdGFibGVyYW5nZTo5NThmM2Y4MDU2Mzg0YjljOGVjMzQ3N2EzN2Q4MjM2N18xLTItMS0xLTEyMzc1_be45eaaf-b5c3-4a5d-9bac-c68e6611c7b8">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA4_89d0de92-81d1-4338-945e-8e557c972f73">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk1_89d0de92-81d1-4338-945e-8e557c972f73">&#9744;</ix:nonNumeric></span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie4b0cbdd6d874801a10a304ed1b6c63e_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 &#160;&#160;&#160;&#160;Other Events</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2021, Cumberland announced the U.S. Food and Drug Administration (FDA) has approved expanded labeling for Caldolor&#174;, an intravenously delivered formulation of ibuprofen to now include use in pre-operative administration. The non-narcotic pain reliever may now be administered just prior to surgery to enable patients to wake up from their procedure in significantly less pain.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The newly FDA-approved label includes information regarding the product&#8217;s indications and usage, appropriate patient populations, clinical study results, potential side effects, patient safety details, and instructions for use in pregnant women, children and other populations.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the release is furnished as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a11-29x21ex991.htm">Exhibit 99.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.461%"><tr><td style="width:1.0%"></td><td style="width:18.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11-29x21ex991.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11-29x21ex991.htm">Press release dated November 29, 2021</a></span></div></td></tr></table></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div id="ie4b0cbdd6d874801a10a304ed1b6c63e_7"></div><div style="margin-top:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:16.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a11-29x21ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3f9abc05324b4f27acde6b44d9b3f8f4_1"></div><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><img alt="image_1.jpg" src="image_1.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:358px"></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:157%">CALDOLOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:157%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:157%"> NOW FDA APPROVED </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:157%">FOR PRE-OPERATIVE ADMINISTRATION</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Dosed prior to surgery, Caldolor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> demonstrated significant reduction in pain intensity</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NASHVILLE, Tennessee (Monday, November 29, 2021) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8211; Cumberland Pharmaceuticals Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(NASDAQ&#58; CPIX), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a specialty pharmaceutical company today announced the U.S. Food and Drug Administration (FDA) has approved expanded labeling for Caldolor</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, an intravenously delivered formulation of ibuprofen to now include use in pre-operative administration. The non-narcotic pain reliever may now be administered just prior to surgery to enable patients to wake up from their procedure in significantly less pain.</font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The newly FDA-approved label includes information regarding the product&#8217;s indications and usage, appropriate patient populations, clinical study results, potential side effects, patient safety details, and instructions for use in pregnant women, children and other populations.</font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Supporting this expanded use of Caldolor, a study of orthopedic surgical pain confirmed the significant pain reduction when the product was administered every six hours (started pre-operatively) with supplemental morphine available on an as needed basis. A total of 185 patients were randomized and treated with either Caldolor</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#174; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">800 mg or placebo administered every six hours (started pre-operatively) and morphine provided on an as needed basis. Efficacy was demonstrated as a statistically significant greater reduction in pain intensity over 24 hours post-operatively for patients treated with Caldolor</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#174; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as compared to those receiving placebo.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dr. Stephen Southworth, an orthopedic surgeon at the Orthopedic Institute of North Mississippi concluded that &#8220;Caldolor</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#174; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">administered pre-operatively should be considered in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Enhanced Recovery After Surgery </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ERAS) protocols for the management of postoperative pain including that of traumatic origin. When administered immediately prior to surgery, patients given Caldolor experience less postoperative pain and a decrease in their opioid use.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Before the pandemic began, healthcare systems across the country were in the midst of a public health mission to control surgical pain while decreasing opioid consumption,&#8221; said A.J. Kazimi, chief executive officer of Cumberland Pharmaceuticals Inc. &#8220;We are proud to see the continued support for Caldolor&#8217;s use in surgical care, with the product&#8217;s approved labeling now including the expanded use of the product prior to surgery. We feel confident that this important development provides additional insights into how intravenous ibuprofen can help healthcare professionals and patients as elective surgeries resume.&#8221;</font></div><div><font><br></font></div><div style="text-indent:5.35pt"><font><br></font></div><div style="height:40.01pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">About Caldolor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%;text-decoration:underline">&#174;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Caldolor is indicated in adults and pediatric patients for the management of mild to moderate pain and management of moderate to severe pain as an adjunct to opioid analgesics, as well as for the reduction of fever. It was the first FDA-approved intravenous therapy for fever. Caldolor is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, patients with a history of asthma or other allergic-type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. Caldolor should be used with caution in patients with prior history of ulcer disease or GI bleeding, in patients with fluid retention or heart failure, in the elderly, those with renal impairment, heart failure, liver impairment, and those taking diuretics or ACE inhibitors. Blood pressure should be monitored during product treatment.</font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For full prescribing information, including boxed warning, visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">www.caldolor.com</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">About Cumberland Pharmaceuticals</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the delivery of high-quality prescription brands to improve patient care. The Company develops, acquires, and commercializes brands for the hospital acute care, gastroenterology and rheumatology market segments. The Company's portfolio of FDA-approved brands includes&#58;</font></div><div style="text-align:justify;text-indent:5.35pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:14.15pt">Acetadote</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">acetylcysteine</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) Injection, for the treatment of acetaminophen poisoning&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:14.15pt">Caldolor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">ibuprofen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) Injection, for the treatment of pain and fever&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:14.15pt">Vaprisol</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">conivaptan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:14.15pt">Vibativ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">&#174; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">telavancin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:14.15pt">Kristalose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">lactulose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:14.15pt">RediTrex</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">(methotrexate) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:14.15pt">Omeclamox</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">-Pak</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">omeprazole, clarithromycin, amoxicillin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) for the treatment of Helicobacter pylori (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">H. pylori</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) infection and related duodenal ulcer disease.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For more information on Cumberland&#8217;s approved products, including full prescribing information, please visit the individual product websites, links to which can be found on the Company&#8217;s website </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.cumberlandpharma.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company also has a series of Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (&#8220;DMD&#8221;), Systemic Sclerosis (&#8220;SSc&#8221;), and Aspirin-Exacerbated Respiratory Disease (&#8220;AERD&#8221;).</font></div><div style="height:40.01pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cpix-20211130.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7410dd42-56a6-4617-b36d-8314ad02a0de,g:2b92fc42-55d8-4534-9ce1-84689eef7112-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cpix="http://cumberlandpharma.com/20211130" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cumberlandpharma.com/20211130">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20211130_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20211130_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20211130_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument">
        <link:definition>0001001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cpix-20211130_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7410dd42-56a6-4617-b36d-8314ad02a0de,g:2b92fc42-55d8-4534-9ce1-84689eef7112-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="cpix-20211130.xsd#DocumentandEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="extended" id="ie4d4bc5c96d84c54a1509fe026cbed62_DocumentandEntityInformationDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f49c9a68-095b-4156-8543-f91ea2d09fd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_DocumentType_f49c9a68-095b-4156-8543-f91ea2d09fd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e4eae20c-7f40-423c-b4aa-3dd05aba96c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_DocumentPeriodEndDate_e4eae20c-7f40-423c-b4aa-3dd05aba96c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_402fb07d-3b0d-4a33-a96a-7ab07ee39dac" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityRegistrantName_402fb07d-3b0d-4a33-a96a-7ab07ee39dac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cd8ecf3c-3c01-46fa-9982-9ee34bcac9f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityCentralIndexKey_cd8ecf3c-3c01-46fa-9982-9ee34bcac9f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9b199bba-6797-40d6-8be3-3b104031d110" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_AmendmentFlag_9b199bba-6797-40d6-8be3-3b104031d110" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_63bc79f2-b801-43ea-8d40-fe85b7ea1931" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityIncorporationStateCountryCode_63bc79f2-b801-43ea-8d40-fe85b7ea1931" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0c7894ba-518f-457c-b7db-2c9a5a5b160a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityFileNumber_0c7894ba-518f-457c-b7db-2c9a5a5b160a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f0832e32-cad1-44fd-a400-08ee5e7726a7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityTaxIdentificationNumber_f0832e32-cad1-44fd-a400-08ee5e7726a7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2fba8c47-1ff7-4aa0-8452-f4b2eb6ca93f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_CityAreaCode_2fba8c47-1ff7-4aa0-8452-f4b2eb6ca93f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3b3d9158-8590-490f-a885-e71cac73d42b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_LocalPhoneNumber_3b3d9158-8590-490f-a885-e71cac73d42b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9608f87e-3be5-478e-a2a7-22ad06aab9c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_WrittenCommunications_9608f87e-3be5-478e-a2a7-22ad06aab9c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_c29aacee-6a86-47ca-ba4e-51345dc6dbd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_SolicitingMaterial_c29aacee-6a86-47ca-ba4e-51345dc6dbd6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_bef43454-dff6-4493-b932-9ad7a217f436" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_PreCommencementTenderOffer_bef43454-dff6-4493-b932-9ad7a217f436" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4e14f122-6f57-4969-a875-010d7e9b56a4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4e14f122-6f57-4969-a875-010d7e9b56a4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_66aeb936-bb3e-4e9c-9cfa-3dc5e77c9f36" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_Security12bTitle_66aeb936-bb3e-4e9c-9cfa-3dc5e77c9f36" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_68938fe4-3166-4830-b2d8-8fe037c8626e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_TradingSymbol_68938fe4-3166-4830-b2d8-8fe037c8626e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e2265f75-89b1-436a-a8a1-81d319bd1d5f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_SecurityExchangeName_e2265f75-89b1-436a-a8a1-81d319bd1d5f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_da51a467-9523-4090-b03b-a61b4bb8d689" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityEmergingGrowthCompany_da51a467-9523-4090-b03b-a61b4bb8d689" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_df463569-af67-4292-8293-762d29ccf712" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressAddressLine1_df463569-af67-4292-8293-762d29ccf712" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b3bfd64f-d1c5-433f-bc20-4eff115166c0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressPostalZipCode_b3bfd64f-d1c5-433f-bc20-4eff115166c0" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c40625ec-0def-4e1d-87ba-4e4b9390ffea" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressCityOrTown_c40625ec-0def-4e1d-87ba-4e4b9390ffea" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f8b7b09c-20ba-4a4f-8c29-ffdcac4ede9d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressStateOrProvince_f8b7b09c-20ba-4a4f-8c29-ffdcac4ede9d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_2de24d7c-8d04-4a0d-b8fe-f594dc1b8ffc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntitiesTable_2de24d7c-8d04-4a0d-b8fe-f594dc1b8ffc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cpix-20211130_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7410dd42-56a6-4617-b36d-8314ad02a0de,g:2b92fc42-55d8-4534-9ce1-84689eef7112-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_1d01e9a9-8ecc-425d-bc04-d0574248ca80_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_04eb4703-54a9-46d2-99ae-629fef51af3a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9715d1a0-eea6-461f-ae48-bdabf1187dde_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4cd05ee1-87da-4655-a895-c53794e19707_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_64f16c0f-5733-47fc-8029-eac469203030_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1beaa4e6-d59e-4fbd-8fb9-00f2a62a7d1e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_09fdbe05-16cc-412d-bcdf-dafcf80b30e5_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_0308f5c3-858b-4e12-8f8d-45c6b63290d1_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7ac7e4da-7f4b-43e9-8825-3207f402ae36_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3f63a194-5852-4dc3-bb12-8c8101cd0045_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f08b98f9-b095-49b8-ae2f-0b2fb62b7011_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_fc91679a-d7c4-4ea0-842a-054f56b920c6_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0d16a586-ebce-4bcf-a898-814be97e97bc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e4f34084-e227-455c-bd7f-1126c0e7ad54_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0cb394f1-39bc-466e-a648-60912a0d509f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_aa9242ed-5394-4cd9-b3a6-0b0f26758984_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cf731db6-85a9-49c4-b5bb-e821f70a3dae_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_63b674df-f070-4e77-b373-5122ff12584d_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_686eb968-51cd-49c2-a36f-e67916d4c04a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_08a425c9-6e72-4564-909f-494fd61e8f5d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c547b4bd-d2dd-4205-a7aa-17be19e46b7c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_12964ff0-aa85-44bf-9439-d243b60a36f8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_07824a3a-6c70-4dde-bb88-016b3f7112fd_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3a923b31-6bf0-4f65-a4e0-dfe8fe46cf46_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c7b78a1c-342c-42fc-a32b-8571c43e2b7f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cpix-20211130_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7410dd42-56a6-4617-b36d-8314ad02a0de,g:2b92fc42-55d8-4534-9ce1-84689eef7112-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="cpix-20211130.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_dc46a7d2-7479-482d-9d43-4a464ef44c95" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_2de24d7c-8d04-4a0d-b8fe-f594dc1b8ffc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dc46a7d2-7479-482d-9d43-4a464ef44c95" xlink:to="loc_dei_EntitiesTable_2de24d7c-8d04-4a0d-b8fe-f594dc1b8ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_2de24d7c-8d04-4a0d-b8fe-f594dc1b8ffc" xlink:to="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f49c9a68-095b-4156-8543-f91ea2d09fd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_DocumentType_f49c9a68-095b-4156-8543-f91ea2d09fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e4eae20c-7f40-423c-b4aa-3dd05aba96c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_DocumentPeriodEndDate_e4eae20c-7f40-423c-b4aa-3dd05aba96c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_402fb07d-3b0d-4a33-a96a-7ab07ee39dac" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityRegistrantName_402fb07d-3b0d-4a33-a96a-7ab07ee39dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cd8ecf3c-3c01-46fa-9982-9ee34bcac9f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityCentralIndexKey_cd8ecf3c-3c01-46fa-9982-9ee34bcac9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9b199bba-6797-40d6-8be3-3b104031d110" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_AmendmentFlag_9b199bba-6797-40d6-8be3-3b104031d110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_63bc79f2-b801-43ea-8d40-fe85b7ea1931" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityIncorporationStateCountryCode_63bc79f2-b801-43ea-8d40-fe85b7ea1931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0c7894ba-518f-457c-b7db-2c9a5a5b160a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityFileNumber_0c7894ba-518f-457c-b7db-2c9a5a5b160a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f0832e32-cad1-44fd-a400-08ee5e7726a7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityTaxIdentificationNumber_f0832e32-cad1-44fd-a400-08ee5e7726a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2fba8c47-1ff7-4aa0-8452-f4b2eb6ca93f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_CityAreaCode_2fba8c47-1ff7-4aa0-8452-f4b2eb6ca93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3b3d9158-8590-490f-a885-e71cac73d42b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_LocalPhoneNumber_3b3d9158-8590-490f-a885-e71cac73d42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9608f87e-3be5-478e-a2a7-22ad06aab9c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_WrittenCommunications_9608f87e-3be5-478e-a2a7-22ad06aab9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_c29aacee-6a86-47ca-ba4e-51345dc6dbd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_SolicitingMaterial_c29aacee-6a86-47ca-ba4e-51345dc6dbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_bef43454-dff6-4493-b932-9ad7a217f436" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_PreCommencementTenderOffer_bef43454-dff6-4493-b932-9ad7a217f436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4e14f122-6f57-4969-a875-010d7e9b56a4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4e14f122-6f57-4969-a875-010d7e9b56a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_66aeb936-bb3e-4e9c-9cfa-3dc5e77c9f36" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_Security12bTitle_66aeb936-bb3e-4e9c-9cfa-3dc5e77c9f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_68938fe4-3166-4830-b2d8-8fe037c8626e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_TradingSymbol_68938fe4-3166-4830-b2d8-8fe037c8626e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e2265f75-89b1-436a-a8a1-81d319bd1d5f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_SecurityExchangeName_e2265f75-89b1-436a-a8a1-81d319bd1d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_da51a467-9523-4090-b03b-a61b4bb8d689" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityEmergingGrowthCompany_da51a467-9523-4090-b03b-a61b4bb8d689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_df463569-af67-4292-8293-762d29ccf712" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressAddressLine1_df463569-af67-4292-8293-762d29ccf712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b3bfd64f-d1c5-433f-bc20-4eff115166c0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressPostalZipCode_b3bfd64f-d1c5-433f-bc20-4eff115166c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c40625ec-0def-4e1d-87ba-4e4b9390ffea" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressCityOrTown_c40625ec-0def-4e1d-87ba-4e4b9390ffea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f8b7b09c-20ba-4a4f-8c29-ffdcac4ede9d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d3a97e4c-6fbe-4dfd-98c4-71c4b7615dee" xlink:to="loc_dei_EntityAddressStateOrProvince_f8b7b09c-20ba-4a4f-8c29-ffdcac4ede9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[0*H4&AO=&]S:&]P(#,N,  X0DE-! 0
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M+" V,34M,CDW+3<W-C8L(')E8F5C8V% ;&]V96QL+F-O;1P"50 "2$\< EH
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ML*+>=GU-%9MJXHPET^:AIQI,EHD@*"7$I6.X/90![:UU5++3RN@F%G-R(_\
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MO)3>U_W<[K"]_$CRZJ=S%N4OMA0V0S$OFW;-I-2M2I+/1ZO+%/8RRM7F&G@
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MM*Y:5>MBB#;^J2IT[Y74^/6$.F,4AOPFU]QX"L]6/,?3JS[+[00X8)A,TG?
M M;A?6Y'-0&T&#2UYB]&0-TF][\;=!Y*[H&!JI*R+DAN1R.N)FD<;.Y^[>U&
M\=FV&]?E9J$MIQE^8W,3#DR/&##N(ZDYRE!."1E(P=>EP;784Z@BHZR!S]P
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MN!Z2%%;1X-+B$;&1$"Q.M^CH*KI!Y4G,"I<%F-&XL::Q'CMI::;15Z@$H2D
M) _L;R  &IP[1[.$W-&>YOS4.,#QP"PJ1WN^2\D_T?[B&XE:A&B;[<453N&W
M8[J7508CLVH]6#GV$R%-LH5\%%M6//!UD-M,-I1?#Z0-=S-AY7/B%\.RM=4$
M"LJ"6\LSYVLND_"+PAV/P1;)T^PK IBJ?1H*E/NN/.>+*J$A>/$D/N8'6ZK
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M+.:;QG5H )R9J/X25#T-3!2U#8H22QX -P1[0T.8'O:=:Z. Y&J,K:JP[6I
MYMV\!P,_UM[5R<=_[NK&I^H^Z(?^Y)Y,4/"3](RC^%OFY6>U *85>^/+A9N3
MB$D[<5ZUW;6J%3VVN!5=1;MTMN+H=?ZHSK'2^6TK4VZUXGB,N^&X$+&2@^8F
ML'Q&*F$L<UP)&VWF^\W,'*^H-K$7%QQ45BE%)/N/CL2PWL[W3E;/JU!L<UC^
M%_>>E5+B<N*S;GVAIVUN[KMOLUE^1!7$J$:X:2W(+"7&IS*$.+2T\LI+3[;:
MT^(" 0<ZSQ"E>*5L\4QDBWB,[@M=:^;22,QQ!*UT-0TU#HI(@R2U\K&XO;46
MT/ @*RFH)3*:(FB)HB:(N4OI5_;8#:#\+I'Y@YKT+^SW]IF_*/-4W;+[&/K^
M"YT<-GZK'^K5YK>*C,/]P+ICP:R6X;D9YYQMEI!!4XXH(2G[Y/;5)Q,$@@*S
MTQ S*W8[PBUOB3NCQ7%/4.V"O+M0=:P])3GRCMJ&3G_*+ 0/,!?EJ'.*QTK+
M#VG<N Z_D,^I;_0.F.60Y_+^K=:MAM-M)0-D+&AV[;5/:IU,A E*$^TMU9[J
M<<4>ZUJ/<J/<G59J:F2>0RRFY*DH86QMW6*2:T+:FB**VILM;ED[GW9>--@&
M/<-[)A(K$GQW%B6(C:FH_L$E*.E"U#V0,Y[Y.NB2JEDB9 X^RR]AROF5HCIH
MV2.F:/:=:_9D%*M<ZWJ+;R;,6YO[8R[;NJ"JI4=R9$GJ8#[C.7HLEN2PKJ00
MKV7FFU8S@].#D$C712U4M/)Z6$V-B.P@@Z]!6BHIHYV>CE%QD>XW'B%^V[NT
MU!WTVOK]FW/#54+=N:"[3JC&#RV2^PZDI6CK00I.03W201[CKY35,E/*V>(V
M<TW'6%]G@9-&Z*07!%BL]!A-TV$S'93TM,(2V@9SA(& /Q#6DDDW*V@6%@HH
M-B+7_KZ*W(73UNW@:*+?;G.2'%B/"\;QU--ME70WUN84M24A2^A 42$I Z?7
M)?5_5;^Q?>MTVMGQ.6G):/58_3>L6]JUK]&J;T[$6QQ VS"I-TT]<Z-3*I$K
M4);<ER._"FQ70ZP^TZVI*T+2H>8(R"I)RE1!^4M9+3N+X38D$'C<$6((*5%+
M'.T,D%[$'M&A4P QKF70HM:FR]N61N1=EVTV 8]>O=<1=9D^.XL2S%9\!@]"
MB4HZ6^WL@9\SD]]=$E7+)$R%Q]EE[=%S<^*T1TT;)'2M&;K7[!8+S[,;"6MP
M^4>JTVT:<JCTRKU636782'W%QF),A76\6&U**64+7E9;;"4!2E$)!4<Y559-
M4N#IC<@ 7XV&E^?6<U\IZ6. %L8L"2>T\N74,EZ-Z=E[<X@]MJA:-V0#4Z!5
M%,+DQ@^XR7"R\V^W[;92H8<:0>Q[XP>Q(UC25<M-*)H39POXBWD5]J::.HC,
M4HNT_ W7CO+AULO<'=ZT;]K% A3KML1$M%"J3@/BP!*0$/!.#@]21VZ@>G)(
MP2=915L\<+Z=CK,?:XYVT7R2DB?*V9S;N;>QY77KM#9:W+%W)NZ[J9 5'K]\
MKB+K,DON+$LQ6/ 8P@DI1TM^S[(&?,Y/?6,E7+)$R%Y]EE[=%S<^*^QTT;)'
MRM'M.M?L%@OO>;:"A;_;6URS+GCR)EO7'%5"J,9F4[%5)85CK;+C2DK"5#V5
M $922#V)TI:F2GE;/$;.:;C('/M7VHIV3QF*30Z\/)9VD46)0*3&@08[42%"
M:0Q'893T-LMH2$I0E([     >0&M+GN<2YQN2MC6AHW1H%&MH-B;8V(C5Z/:
MM/52XMQUF37YD=+[BV1,DD*?6VA2B&DK6.LH1TIZE*5C*B3OJ:R6H+3,;EH#
M1U#2_/K.:TP4T<.\(Q:YOVGRZ@LO?VW]#W4LVHV[<E)I]=H5785&FP)S"7XT
MIM7FA:% A0^_\ =:H9I(GB2(D.&A&H6R6)DC2R07!X%:6>Y:FW4RD&BRY^Y$
M^T5-ADVS+OJKOT9;0_P*F%2#UL^[PE$MD=BG';4L,>J0=\!H?_F#&AW7>VO3
MJHWZ&@(W"7%O^7?=;NOIT:+?-)I,6@4J-!@QF(<*$TAB.PPV&VF&T@)2A*1V
M2D   #L -0SG%Q+G&Y*E6M#0&MT"USO7PBV9OW?-$N:MIN.)<%NPY-/@5"BW
M#/H\AF/(4VIYHKBNME25EELD*S\P:[Z3$YZ>-T3+%KB"06M<+B]M0>97'4X?
M#.\2/N"+@$.(UUT(7OV@X<:'LI59LRE52]Z@[.:2RXFN794JRV@)5U H1*><
M2A63W4D D=B<:UU5<^< /:T6_P K6M\@%E343("2PN-^;G'S)4_UQKK5>ZAR
MQ]KI46HTR,+UI%I5AUUZ?:M+NZI0:!*+RBIY)A-/);0VXI2BMML);5U'*3DY
MFFX_5BSCNEXT<6M+A;3,B]QP)S42<%IC=HW@TZM#G!O<#X#);WMRW8%H6_!I
M-*AQ:=3*9';B1(D9H-,QF6TA*&T(& E*4@  =@ -0[WN>XO>;DYDJ48QK&AK
M18!>TC.L5DHMLULQ;FP%A,VS:L%5-HL>5+F-L%]Q[I=DR7)+RNI9*O:>><5C
M.!U8&  -=%552U$GI9C=V0[@ / +134T<$?HXA89GO-SXE2G7.MZBVUVS-N[
M--5Y%NP#!3<U;EW#407W'?'FRE!;[OMD]/4H ]*<)'N UT5%5+/NF4WW0&CJ
M&BT04T<.]Z,6WB2>LZJ2383-1B.QY#3;[#Z"VXVXD*0XDC!20>Q!'8@ZT D&
MX6X@$6*T/&Y;NW="87!MZ;N#9]O/*6IR@6[>E4I=('625);C,OA#"#D^RSX:
M>_EJ8..U+O:D#7._S.8TN[R,^VZB_H:G&3"YHY!S@.X'+LLMO;7;6V]LI8%+
MM:U*1"H5OT9GP(<&(CH:83DJ./>25%2BHDE2E$DDDG4945$D\AFF-W'4E2$$
M#(6".,6 X+'5S8BU[EWJH>X,^GKEW3;-.E4NE27)#BFX#,E2"^6VNKPTN+\-
M"2YT]?2GISTD@[&5DK8'4S39KB">FVF>MART6#J6-TPG</: ('1?7+3MU7UO
MAL9;'$;MG4+1N^G&J4*IEI;K(?<8<0MIU#K3C;C:DK;<0XA"DK0H*24@@Z^4
ME7+32B:$V<.W7(Y'(@A?:FFCGC,4HN"I6PR(["$ J4$ #*CE1^DGWG7,5O 6
MIMRN":QMT=UI=[3%W?2[FJ%/CTJ5,H=UU.CF5&86XMEMQ,5]M*@A3SA!()]L
MZDJ?%IXHA -TM!) <UKK$VOJ#R"CY\-AED]*ZX<1;)SAD.HA3C:O:VG[/VJ*
M/3)EP3HP>6_XM9K,JK2>I7F/&DN..=(QV3U8'N UR5%0Z9^^X 'H :.X !=5
M/ V%FXTD]9)/>;E87??AKM;B*B4@7 W5V)UO253*34J35I5+J%,>4@H4MI^.
MM"QU()24DE*@<$'6VCKY:8GT=K.R((!!'2""M5511U &_>XT()!':%X]D.$^
MT-A;BJM=I;58JMSUUEJ-4*]7:M(J]4E,M$EMGQY"U*0RDJ)#:.E&23TY.=9U
M>)35#1&^P:,PT -%SQL./2<U\IJ&* E[;EQU)))[SPZ%LK7 NQ-$31$T1-$7
M-'TCS8^Y^).VMA+'LRF+J]R7#>S\>'&2H(3VI[JEK6H]D-H0E2U*/8)23]&K
MUL15Q4SYYYS9K6"_>JGM33R3MBBB%W%WP7LX2_1ZJ%ME08<C<&^*I6JOT!3T
M2A-IAPFE>](=<2IUP?NL-Y^ U\Q';225Q%-& .9S/=H/%=-#@/HVCTK\^C]?
MT5V=I.$?;W9-IHT*W(B)+('3*EJ5+D CWA;I44G][C55J<3J:C[1^7(9#P4U
M%211Z#OS6R0,:X%TIHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)H
MB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(F
MB)HBA-WV]!JF]EG39$9IZ53(E27%=4,J84M,="BGX$I)'WB==43W"![0<B6_
M%<LC 9F$\+_!3;7*NI-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1
M-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31
#%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cpix-20211130_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cpix-20211130.xsd" xlink:type="simple"/>
    <context id="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-11-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xMC9mcmFnOjg0OTI5YzM0MTMyMzRkYmQ5ZWEyNzZhNTBjNDdhOWI4L3RhYmxlOjQ5OTE4Y2YxNWJhZjRjODdhNzY4MDI0OTM5NWNjYTRhL3RhYmxlcmFuZ2U6NDk5MThjZjE1YmFmNGM4N2E3NjgwMjQ5Mzk1Y2NhNGFfMi0xLTEtMS0xMjM3NQ_a9871e7e-ef46-47a8-8bc5-18b91291fac1">0001087294</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xMC9mcmFnOjg0OTI5YzM0MTMyMzRkYmQ5ZWEyNzZhNTBjNDdhOWI4L3RhYmxlOjQ5OTE4Y2YxNWJhZjRjODdhNzY4MDI0OTM5NWNjYTRhL3RhYmxlcmFuZ2U6NDk5MThjZjE1YmFmNGM4N2E3NjgwMjQ5Mzk1Y2NhNGFfMy0xLTEtMS0xMjM3NQ_eb811f46-5b60-452f-8826-bc3942b15761">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAw_b4e268d1-43cb-4ca4-b29c-85301825fb87">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzY_a8a1f2a3-fed2-4a3c-8f6a-e0bc3f33c812">2021-11-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAx_1f60eb61-433c-4af9-8364-c18cc44012bc">CUMBERLAND PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6Y2ZlYTRjN2I1OTNlNDliOThkZjU0MDVmNjE4MWQ2YjIvdGFibGVyYW5nZTpjZmVhNGM3YjU5M2U0OWI5OGRmNTQwNWY2MTgxZDZiMl8wLTAtMS0xLTEyMzc1_8a8aca24-6b25-45df-bd09-e1a263a0dbcc">TN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6Y2ZlYTRjN2I1OTNlNDliOThkZjU0MDVmNjE4MWQ2YjIvdGFibGVyYW5nZTpjZmVhNGM3YjU5M2U0OWI5OGRmNTQwNWY2MTgxZDZiMl8wLTEtMS0xLTEyMzc1_eb8a4631-acc5-481f-befb-02fdb0da5897">001-33637</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6Y2ZlYTRjN2I1OTNlNDliOThkZjU0MDVmNjE4MWQ2YjIvdGFibGVyYW5nZTpjZmVhNGM3YjU5M2U0OWI5OGRmNTQwNWY2MTgxZDZiMl8wLTMtMS0xLTEyMzc1_527d8ba5-1cb6-4093-b265-24a6388b880e">62-1765329</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAy_584cd7c8-d548-48bd-b96c-794c5407e3b2">2525 West End Avenue, Suite 950</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk2_152f9235-c113-42bf-9526-92c066be93db">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzAz_5ecf761a-60d8-4122-afe1-28ac425da629">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA0_f7392f81-e683-4151-9b2f-4f8a49b4d37f">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA1_558821c7-ba1a-4765-85d3-32941e88bd9d">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk3_5b0e9a6f-52b8-415b-be52-f783fcc52c8a">255-0068</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA2_15083984-2a50-43ac-a181-9a5706490f36">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA3_d5ee83f7-0b1e-4dee-8961-a18f2ee063ae">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk4_b9ea5fc2-30c4-463c-8959-26a59caf5e3e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk5_f94b1721-ff33-4692-9b79-11f417807c4b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6OTU4ZjNmODA1NjM4NGI5YzhlYzM0NzdhMzdkODIzNjcvdGFibGVyYW5nZTo5NThmM2Y4MDU2Mzg0YjljOGVjMzQ3N2EzN2Q4MjM2N18xLTAtMS0xLTEyMzc1_4316548f-33b2-4f54-a370-2f3f2bc08a96">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6OTU4ZjNmODA1NjM4NGI5YzhlYzM0NzdhMzdkODIzNjcvdGFibGVyYW5nZTo5NThmM2Y4MDU2Mzg0YjljOGVjMzQ3N2EzN2Q4MjM2N18xLTEtMS0xLTEyMzc1_97d27146-f886-4212-8426-4c6488439ae7">CPIX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGFibGU6OTU4ZjNmODA1NjM4NGI5YzhlYzM0NzdhMzdkODIzNjcvdGFibGVyYW5nZTo5NThmM2Y4MDU2Mzg0YjljOGVjMzQ3N2EzN2Q4MjM2N18xLTItMS0xLTEyMzc1_be45eaaf-b5c3-4a5d-9bac-c68e6611c7b8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNzA4_89d0de92-81d1-4338-945e-8e557c972f73">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany
      contextRef="i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YjBjYmRkNmQ4NzQ4MDFhMTBhMzA0ZWQxYjZjNjNlL3NlYzplNGIwY2JkZDZkODc0ODAxYTEwYTMwNGVkMWI2YzYzZV8xL2ZyYWc6YjdkMmFkN2RkMDg3NGE2YzhhYTRiNjExMTIxMDhkYjMvdGV4dHJlZ2lvbjpiN2QyYWQ3ZGQwODc0YTZjOGFhNGI2MTExMjEwOGRiM18xNjk1_89d0de92-81d1-4338-945e-8e557c972f73">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139765891154328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Nov. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 30,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CUMBERLAND PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001087294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1765329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-0068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CPIX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2525 West End Avenue, Suite 950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MAC,P8O<!O%\I98\W[H2:_X-A^"]02P,$%     @ G8Y^4Y^@&_"Q @  X@P
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ G8Y^4P=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "=CGY3^$O:E^X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "=CGY3F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )V.?E.=
M\#5!3 0  &P0   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "=CGY3GZ ;\+$"  #B#   #0
M    @ &/#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( )V.?E.7BKL<P
M !,"   +              "  6L/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M )V.?E,<.&7J/P$  #P"   /              "  500  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " "=CGY3)!Z;HJT   #X 0  &@
M@ ' $0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "=
MCGY399!YDAD!  #/ P  $P              @ &E$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  #O$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cpix-20211130.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cumberlandpharma.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cpix-20211130.htm">cpix-20211130.htm</File>
    <File>a11-29x21ex991.htm</File>
    <File>cpix-20211130.xsd</File>
    <File>cpix-20211130_def.xml</File>
    <File>cpix-20211130_lab.xml</File>
    <File>cpix-20211130_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cpix-20211130.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "cpix-20211130_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cpix-20211130.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cpix-20211130_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cpix-20211130_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cpix-20211130.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cpix",
   "nsuri": "http://cumberlandpharma.com/20211130",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20211130.htm",
      "contextRef": "i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information Document",
     "role": "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20211130.htm",
      "contextRef": "i879e1800b95f405cb8e90641ffcaae39_D20211119-20211119",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-21-024264-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-21-024264-xbrl.zip
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M3DXJ5%'4BGSMLE24ILVY""Y:YRU3X95/XK,*O*C(U<T:RI?!/8"#*,U8Y%T
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M8,?KQD_/CB:3!^9,[>JJ@(\0)H^'?WR\V$6:E^W,YZO9XYB9*0I$W,_0WM_
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MV\FJ;&'=OBWZ?LKIM('%D_>89\]X0]<^GQT]GNX^NO^$.#OZ'U!+ P04
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M$RO9@@DK\?:%["39EK/1A-H7QJX\>VT&KJ2KS;]/Q65^E\UA3 D.> )"&6%
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M?]I_43I^]W]02P$"% ,4    " "=CGY36D/T.IL-  "A30  $@
M    @ $     83$Q+3(Y>#(Q97@Y.3$N:'1M4$L! A0#%     @ G8Y^4\IO
M,+2>%   TI$  !$              ( !RPT  &-P:7@M,C R,3$Q,S N:'1M
M4$L! A0#%     @ G8Y^4ZW'?&R2 @  V0@  !$              ( !F"(
M &-P:7@M,C R,3$Q,S N>'-D4$L! A0#%     @ G8Y^4\*;S!5L!P   C,
M !4              ( !624  &-P:7@M,C R,3$Q,S!?9&5F+GAM;%!+ 0(4
M Q0    ( )V.?E.VOCNZ*PL  ,%E   5              "  ?@L  !C<&EX
M+3(P,C$Q,3,P7VQA8BYX;6Q02P$"% ,4    " "=CGY39NUX;"$'  !P-@
M%0              @ %6.   8W!I>"TR,#(Q,3$S,%]P<F4N>&UL4$L%!@
0   &  8 AP$  *H_      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
